Skip to main content
Tetsuhiko Taira on Muck Rack

Tetsuhiko Taira

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Tetsuhiko

Contact Tetsuhiko, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Prospective observational study of atezolizumab plus nab-paclitaxel in patients with metastatic triple-negative breast cancer: JBCRG-C08/ATTRIBUTE

|
By Tatsunori Shimoi, Nobuhiro Shibata, Masahiro Kitada, Michiko Tsuneizumi, Yukinori Ozaki, Naoki Hashimoto, Miki Yamaguchi, Yutaka Yamamoto, Norikazu Masuda, Hiroshi Tada, Takashi Yamanaka, Yuichiro Kikawa, Tetsuhiko Taira, Mari Oba, Naoki Niikura, Mitsugu Yamamoto, Yumi Fujimoto, Sayuri Akiyoshi, Shizuka Nakagawa, Taizo Takahashi
| Nature Verified
Abstract The JBCRG-C08/ATTRIBUTE (UMIN000041747) study assessed atezolizumab plus nab-paclitaxel’s safety and effectiveness in a metastatic triple-negative breast cancer population, including IMpassion130-ineligible patients. The primary outcome was incidence of investigator-assessed adverse events (AEs).
Open in Who Shared Issue with article?
|
By Masakuni Serizawa, Akira Ono, Haruyasu Murakami, Yasuhiro Koh, Norimitsu Kasahara, Hirotsugu Kenmotsu, Rina Umehara, Yasushi Hisamatsu, Kazushige Wakuda, Shota Omori, Kazuhisa Nakashima, Tetsuhiko Taira, Tateaki Naito, Keita Mori, Masahiro Endo
| secure.jbs.elsevierhealth.com
Open in Who Shared Issue with article?
See all 2 articles